RSLS
ReShape Lifesciences Inc.
-48.86%
$5.91 - $3.02
Feb 8th 2023 - Mar 22nd 2023
Feb, 17, 2023
$RSLS patent, approved, patent approved, patent ap... See more
Feb, 17, 2023
$RSLS it’s a great squeeze scenario, fill the $12 ... See more
AUPH
Aurinia Pharmaceuticals Inc
3.07%
$8.48 - $8.74
Feb 8th 2023 - Mar 22nd 2023
Mar, 16, 2023
Sales improving, patent safe, patent extension 203... See more
Mar, 14, 2023
That together with no competition in the field, pa... See more
No reviews available.
Feb, 17, 2023
$RSLS patent, approved, patent approved, patent approved…it’s going up up and away
Feb, 17, 2023
$RSLS it’s a great squeeze scenario, fill the $12 daily gap, and don’t forget the patent
Feb, 17, 2023
$RSLS great patent and more news coming
Feb, 17, 2023
$RSLS nice formation, great, volume, strong rsi, and let’s not forget patent was approved
Feb, 17, 2023
$RSLS The good old patent pump! 😂
Mar, 16, 2023
Sales improving, patent safe, patent extension 2037, increase in insurance covering.
Mar, 14, 2023
That together with no competition in the field, patent life, IPR out of the way is a mix of cocktails that favors BO.
Mar, 10, 2023
Blockbuster drug with improving sales and long patent life
Mar, 1, 2023
$AUPH patent is safe.
Feb, 6, 2023
It was easy when you had that patent lock on you.
Feb, 6, 2023
The patent challenges are now over and IP protection is very solid.
Feb, 1, 2023
$AUPH The BBT TRX/NRX numbers are showing a significant jump, the patent challenges are over and new patents solidify the IP, the revenue outlook Peter provided is obviously very easy to beat, especially if TRX/NRX numbers continue high.
Jan, 31, 2023
Anyway, the Patent’s they filed for again Europe and US, what’s the guess for approval and think that would be a big plus on BO.